|
Laboratorio Reig Jofre S.A. is a pharmaceutical and health products company engaged in the manufacturing, research, development, and commercialization of pharmaceuticals, biotechnological products, nutritional supplements, medical devices, cosmetics, and food products. The company operates through the production of pharmaceutical specialties for both its own commercialization and third-party clients, alongside the provision of research and development services. Its business activities include the import, export, and wholesale and retail distribution of authorized dietary supplements, dietetic products, and cosmetics. Additionally, the group focuses on the elaboration and research of active principles and nutraceutical ingredients derived from natural sources, aimed at disease prevention or nutritional supplementation in functional foods, with a focus on patenting and licensing these innovations to third parties. Summarised from the company's own disclosures, fiscal year ended Dec 2025 |
Industry Drug Manufacturers - General | Homepage reigjofre.com |
| Sector Healthcare | IR page reigjofre.com/en/investors | |
|
Tags
pharmaceuticals, nutraceuticals, medical devices, cosmetics, dietetic products, research and development, licensing, functional foods
|
Press page — |
Metrics
| Valuation | |
|---|---|
| Market cap | € 221.761M |
| Market cap (USD) | $ 245.09M |
| P/E | 33.13 |
| PEG | — |
| P/BV | 0.99 |
| P/S | 0.67 |
| P/OCF | 238.45 |
| P/FCF | -16.10 |
| Dividend yield | 12.1% |
| Turnover / mcap | — |
| Returns | |
|---|---|
| ROE | 2.3% |
| ROI | 2.2% |
| ROIC | 1.5% |
| Profit margin | 1.5% |
| Growth | |
|---|---|
| Revenue growing | No |
| Profits growing | No |
| Revenue up 3y | No |
| Revenue up 5y | No |
| Earnings growth 3y (net profit CAGR) | -14.8% |
| Quality | |
|---|---|
| Profitable | Yes |
| Margin expanding | No |
| Buying back stock | No |
| Diluting (TTM) | — |
| Debt/Equity | — |
| Podcast bulls (TTM) | Sign up |
| Podcast bears (TTM) | Sign up |
| Podcast sentiment (TTM) | Sign up |
| Podcast sentiment % (TTM) | Sign up |
| News sentiment (TTM) | 0 |
| Quality score | -38.9% |
| Insiders | |
|---|---|
| Buys, 1w | Sign up |
| Buys, 1m | Sign up |
| Buys, 1y | Sign up |
| Sells, 1w | Sign up |
| Sells, 1m | Sign up |
| Sells, 1y | Sign up |
Sign up to see this company's insider trades
| Figure | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 | FY 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 331.097M | 338.895M | 316.088M | 271.15M | 236.231M | 230.079M | 200.207M | 180.468M | 167.983M | 161.134M | 156.91M | 33.284M | 31.37M | 29.926M | 29.485M | 38.841M |
| Net profit | 4.998M | 10.467M | 9.397M | 8.106M | 5.08M | 5.666M | 4.939M | 9.253M | 8.811M | 7.667M | 8.75M | 2.311M | 953K | -6K | 16.066M | -22.618M |
| Free cash flow | -13.776M | 11.076M | 6.652M | 5.201M | -4.728M | 18.381M | 5.832M | — | — | — | — | — | — | — | — | — |
Filed figures
Lines the statements and their notes report beside the headline figures, read from the filings' XBRL as filed (no restatement applied), with figures computed from one filing's own lines. Cash-flow lines carry their cash direction: an outflow is negative. Each period links to its filing; a figure's period, report date and tag are in its tooltip.
| Figure | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|
| Balance sheet detail | |||||||
| Trade receivables (EUR) | 40.5M | 42.6M | 44.4M | 49.8M | 55.9M | 56M | 65.3M |
| ↳ YoY growth | +5.1% | +4.2% | +12.1% | +12.2% | +0.3% | +16.5% | |
| ↳ 5y CAGR | +6.7% | +8.9% | |||||
| Lease liabilities (EUR) | 41.2M | 20.9M | 20M | 17.3M | 14.7M | 12.5M | 21.1M |
| Cash and deposits (EUR) | 10.2M | 11.6M | 5.07M | 6.45M | 5.53M | 10.5M | 10.5M |
| Intangible assets (EUR) | — | 82.8M | 77.7M | 70.9M | 63.1M | 55.3M | 69.6M |
| Cash flow detail | |||||||
| Operating cash flow (EUR) | 11.7M | 22.5M | 14.5M | 16.1M | 19.1M | 31.3M | 1.51M |
| Purchases of property, plant and equipment (EUR) | -5.85M | -4.12M | -19.2M | -10.9M | -12.5M | -20.3M | -15.3M |
| Purchases of intangible assets (EUR) | -25.3M | -11.7M | -537,000 | -453,000 | -307,000 | -519,000 | -3.01M |
| Change in receivables (cash effect) (EUR) | -8.56M | -1.39M | -1.75M | -3.08M | -4.73M | -1.23M | -6.94M |
| Change in inventories (cash effect) (EUR) | -4.1M | -3M | -7.11M | -1.06M | -13.9M | -2.07M | 2.53M |
| Change in payables (cash effect) (EUR) | 6.32M | 1.45M | 1.85M | 855,000 | 6.85M | -254,000 | -9.91M |
| Dividends paid (cash effect) (EUR) | -359,000 | -88,000 | -55,000 | -53,000 | -41,000 | -25,000 | -32,000 |
| Share buybacks (cash effect) (EUR) | -238,000 | -628,000 | -753,000 | -363,000 | -20,000 | -3,000 | -79,000 |
| Interest paid (cash effect) (EUR) | -1.05M | -990,000 | -883,000 | -1.04M | -1.23M | -1.98M | -1.65M |
| Income taxes paid (cash effect) (EUR) | -1.33M | -1.64M | -913,000 | -883,000 | -1.47M | 289,000 | 743,000 |
| Operating cash flow before change in receivables (EUR) | 20.2M | 23.9M | 16.2M | 19.2M | 23.8M | 32.6M | 8.45M |
| Free cash flow (OCF - PPE - intangibles) (EUR) | -19.5M | 6.64M | -5.27M | 4.75M | 6.35M | 10.6M | -16.8M |
| Income detail | |||||||
| Total comprehensive income (EUR) | 4.99M | 5.98M | 5.1M | 6.54M | 9.8M | 10.3M | 6.02M |
| Comprehensive income to owners (EUR) | 4.99M | 5.98M | 5.11M | 6.54M | 9.81M | 10.2M | 6.04M |
| Reported | Feb 26, 2021 | Mar 7, 2022 | Mar 7, 2022 | Feb 28, 2023 | Feb 29, 2024 | Feb 28, 2025 | Feb 27, 2026 |
Sign up to see institutional holdings
Sign UpPodcast Mentions
Sign up to see podcast mentions and sentiment
Sign UpInside information and other relevant information filed with the CNMV, newest first, titles as filed, own-share transactions and liquidity-contract reports included. The link opens the filed document.
Prompts
Click prompts to add them under the company line, click again to take one out, then copy the result into your AI chat. Shared by Asian Century Stocks and Uncovered Thai Stocks. Thank you.